About
Capital Point is an investment company traded on the Tel Aviv Stock Exchange with a portfolio of more than 30 companies at different development stages. The company has accumulated vast experience in the process of screening, evaluating, and mentoring early-stage companies. Capital Point was originally focused on early-stage science-based companies and managed two technology incubators. In 2012, it decided to diversify its portfolio and to be more opportunity oriented, adding significant value to its portfolio to the benefit of shareholders in the short, medium, and long-range. As of today, Capital Point makes investments in the field Biomed and other life sciences technologies.
Portfolio
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Capital Point's primary investment focus as of today?
- As of today, Capital Point makes investments in the field of Biomed and other life sciences technologies.
- When was Capital Point founded and what was its initial investment strategy?
- Capital Point was founded in 2000 and originally focused on early-stage science-based companies, managing two technology incubators.
- How did Capital Point's investment strategy evolve in 2012?
- In 2012, Capital Point diversified its portfolio to be more opportunity-oriented, moving beyond its initial focus on early-stage science-based companies.
- Can you name a notable exit for Capital Point and its nature?
- Capital Point had an exit in March 2019 with Enlivex Therapeutics through a Reverse Merger Event on NASDAQ.
- What is the most recent investment made by Capital Point according to startupim data?
- Capital Point's most recent investment was $40,000,000 in ConTiPi Medical in June 2023.
- Which sectors are most represented in Capital Point's portfolio companies?
- The most represented sector in Capital Point's portfolio is Health Tech & Life Sciences, followed by Business Software.
- What is Capital Point's typical investment range?
- Capital Point's investment range is typically between $100,000 and $10,000,000.
- What stages of funding does Capital Point typically participate in?
- Capital Point typically participates in Seed, A Round, and B Round funding stages.
- Has Capital Point made any significant investments in the AI sector recently?
- Yes, Capital Point invested $2,500,000 in Visionary.ai in February 2022, following an earlier $4,500,000 investment in May 2021.